Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D B Brettler

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Archives of Internal Medicine|June 1, 1988
Human immunodeficiency virus isolation studies and antibody testing. Household contacts and sexual partners of persons with hemophiliaD B Brettler, A D Forsberg, P H Levine, et al.
Transfusion|April 1, 1996
Anaphylaxis after treatment with recombinant factor VIIIR I Shopnick, M Kazemi, D B Brettler, et al.
American Journal of Hematology|January 1, 1985
A long-term study of hemophilic arthropathy of the knee joint on a program of Factor VIII replacement given at time of each hemarthrosisD B Brettler, A D Forsberg, F D O'Connell, et al.
Hepatology (Baltimore, Md.)|March 1, 1985
Epidemiology and clinical impact of hepatitis D virus (delta) infectionI M Jacobson, J L Dienstag, B G Werner, et al.
Nature|November 22, 1984
Aetiology of AIDS--antibodies to human T-cell leukaemia virus (type III) in haemophiliacsL W Kitchen, F Barin, J L Sullivan, et al.
The Journal of Pediatrics|November 1, 1987
Isolation of human immunodeficiency virus from hemophiliacs: correlation with clinical symptoms and immunologic abnormalitiesC A Andrews, J L Sullivan, D B Brettler, et al.
Annals of Internal Medicine|July 1, 1990
Low risk for hepatitis C in hemophiliacs given a high-purity, pasteurized factor VIII concentrate. International Study GroupP M Mannucci, K Schimpf, D B Brettler, et al.
The Journal of Experimental Medicine|December 1, 1991
Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificitiesR A Koup, C A Pikora, K Luzuriaga, et al.
Blood|April 1, 1994
Immune status of human immunodeficiency virus seropositive and seronegative hemophiliacs infused for 3.5 years with recombinant factor VIII. The Kogenate Study GroupP M Mannucci, D B Brettler, L M Aledort, et al.
AIDS Research and Human Retroviruses|April 1, 1994
Normal immune function and inability to isolate virus in culture in an individual with long-term human immunodeficiency virus type 1 infectionT C Greenough, M Somasundaran, D B Brettler, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Archives of Internal Medicine|June 1, 1988
Human immunodeficiency virus isolation studies and antibody testing. Household contacts and sexual partners of persons with hemophiliaD B Brettler, A D Forsberg, P H Levine, et al.
Transfusion|April 1, 1996
Anaphylaxis after treatment with recombinant factor VIIIR I Shopnick, M Kazemi, D B Brettler, et al.
American Journal of Hematology|January 1, 1985
A long-term study of hemophilic arthropathy of the knee joint on a program of Factor VIII replacement given at time of each hemarthrosisD B Brettler, A D Forsberg, F D O'Connell, et al.
Hepatology (Baltimore, Md.)|March 1, 1985
Epidemiology and clinical impact of hepatitis D virus (delta) infectionI M Jacobson, J L Dienstag, B G Werner, et al.
Nature|November 22, 1984
Aetiology of AIDS--antibodies to human T-cell leukaemia virus (type III) in haemophiliacsL W Kitchen, F Barin, J L Sullivan, et al.
The Journal of Pediatrics|November 1, 1987
Isolation of human immunodeficiency virus from hemophiliacs: correlation with clinical symptoms and immunologic abnormalitiesC A Andrews, J L Sullivan, D B Brettler, et al.
Annals of Internal Medicine|July 1, 1990
Low risk for hepatitis C in hemophiliacs given a high-purity, pasteurized factor VIII concentrate. International Study GroupP M Mannucci, K Schimpf, D B Brettler, et al.
The Journal of Experimental Medicine|December 1, 1991
Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificitiesR A Koup, C A Pikora, K Luzuriaga, et al.
Blood|April 1, 1994
Immune status of human immunodeficiency virus seropositive and seronegative hemophiliacs infused for 3.5 years with recombinant factor VIII. The Kogenate Study GroupP M Mannucci, D B Brettler, L M Aledort, et al.
AIDS Research and Human Retroviruses|April 1, 1994
Normal immune function and inability to isolate virus in culture in an individual with long-term human immunodeficiency virus type 1 infectionT C Greenough, M Somasundaran, D B Brettler, et al.
Pageof 6